About AltruBio
AltruBio is focused on developing targeted antibody therapeutics for the treatment of cancer and immune related inflammatory diseases.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B
Global Headquarters
San Francisco, United States
Team Size
11–50 employees
Tracked Since
Nov 8, 2026
Web & Domain Identity
Official Website
altrubio.com
Domain Registered Date
Undisclosed
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised $225,000,000 · Series-B
Backed by Biotechnology Value Fund
- Capital Raise
Raised $63,000,000 · Series-A
Backed by aMoon Fund
Investors & Backers
aMoon Fund
Lead
Biotechnology Value Fund
Lead
Blackstone
CAM Capital
Cormorant Asset Management
Delos Capital
RA Capital Management
Soleus Capital
Funding History
Series-B equity
· May 21, 2024
Round backers: Biotechnology Value Fund
$225,000,000 fundraisingfox.com
Series-A equity
· Apr 15, 2021
Round backers: aMoon Fund
$63,000,000 altrubio.com
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allTesorai
tesorai.com
Seed Nov 2026
Commit Biologics
commitbio.com
Seed Aarhus · Nov 2026
Human Biome
human-biome.com
Series-A Warsaw · Nov 2026
MedInTech
medintech.co.kr
Series-B Seoul · Nov 2026
Ace Padel
acepadel.com
Seed Bradenton, United States · Nov 2026
Mentix
mentix.world
Pre-Seed London, United Kingdom · Nov 2026